Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors. 125I brachytherapy is a safe method with a curative effect.
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2022-12-01
|
| Series: | Insights into Imaging |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13244-022-01327-z |
| _version_ | 1811188247645126656 |
|---|---|
| author | Wenliang Zhu Zhihui Zhong Huzheng Yan Huanqing Guo Meigui Xiao Xu He Fei Gao Fujun Zhang |
| author_facet | Wenliang Zhu Zhihui Zhong Huzheng Yan Huanqing Guo Meigui Xiao Xu He Fei Gao Fujun Zhang |
| author_sort | Wenliang Zhu |
| collection | DOAJ |
| description | Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors. 125I brachytherapy is a safe method with a curative effect. |
| first_indexed | 2024-04-11T14:16:21Z |
| format | Article |
| id | doaj.art-fec9db1df2394da8a52d54779747d124 |
| institution | Directory Open Access Journal |
| issn | 1869-4101 |
| language | English |
| last_indexed | 2024-04-11T14:16:21Z |
| publishDate | 2022-12-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Insights into Imaging |
| spelling | doaj.art-fec9db1df2394da8a52d54779747d1242022-12-22T04:19:25ZengSpringerOpenInsights into Imaging1869-41012022-12-011311910.1186/s13244-022-01327-zClinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablationWenliang Zhu0Zhihui Zhong1Huzheng Yan2Huanqing Guo3Meigui Xiao4Xu He5Fei Gao6Fujun Zhang7Department of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Interventional Radiology, The Third Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterZhuHai Interventional Medical Center, ZhuHai People’s Hospital (ZhuHai Hospital Affiliated With Jinan University), Jinan UniversityDepartment of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Minimally Invasive and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterKey points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors. 125I brachytherapy is a safe method with a curative effect.https://doi.org/10.1186/s13244-022-01327-z125I brachytherapyHepatocellular carcinomaLocal residual or recurrentThermal ablation |
| spellingShingle | Wenliang Zhu Zhihui Zhong Huzheng Yan Huanqing Guo Meigui Xiao Xu He Fei Gao Fujun Zhang Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation Insights into Imaging 125I brachytherapy Hepatocellular carcinoma Local residual or recurrent Thermal ablation |
| title | Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| title_full | Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| title_fullStr | Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| title_full_unstemmed | Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| title_short | Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| title_sort | clinical efficacy of ct guided 125i brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation |
| topic | 125I brachytherapy Hepatocellular carcinoma Local residual or recurrent Thermal ablation |
| url | https://doi.org/10.1186/s13244-022-01327-z |
| work_keys_str_mv | AT wenliangzhu clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT zhihuizhong clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT huzhengyan clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT huanqingguo clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT meiguixiao clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT xuhe clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT feigao clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation AT fujunzhang clinicalefficacyofctguided125ibrachytherapyinpatientswithlocalresidualorrecurrenthepatocellularcarcinomaafterthermalablation |